The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population

J-J Wang1, L-Q Jiang, B He

  • 1Department of Neurology, Beijing Children's Hospital, The Capital Medical University, Beijing, China.

Insights

Genetic variations in CTLA-4 and CD28 genes are linked to idiopathic childhood ischemic stroke. Specific polymorphisms in CTLA-4 and CD28 may increase the risk of this condition in children.

Area of Science:

  • Genetics
  • Immunology
  • Pediatric Neurology

Background:

  • Autoimmune vasculitis is a suspected cause of idiopathic childhood ischemic stroke.
  • Polymorphisms in CTLA-4 and CD28 genes are associated with immune vasculitides like SLE and Behçet's disease.

Purpose of the Study:

  • To investigate the association between genetic variants in CTLA-4 and CD28 genes and idiopathic childhood ischemic stroke.
  • To analyze the risk conferred by specific single nucleotide polymorphisms (SNPs) in these genes.

Main Methods:

  • A case-control study design was employed.
  • Genotyping of two SNPs in the CTLA-4 gene and one SNP in the CD28 gene was performed.
  • 51 patients with idiopathic ischemic stroke and 74 healthy controls from mainland China were included.

Main Results:

  • The CTLA-4+49A/G SNP showed a nominal association with the disease (P = 0.012).
  • Homozygous carriers of the G allele of CTLA-4+49A/G were more prevalent in patients (P = 0.008).
  • The CD28IVS3 +17TT genotype was more common in patients (P = 0.039).

Conclusions:

  • Polymorphisms in CTLA-4 and CD28 genes may contribute to the risk of idiopathic childhood ischemic stroke.
  • No correlation was found between specific genotypes and clinical features of the stroke.